| 7/5/2012 | CV | Market Commentary: Convertibles market quiet; Navistar steady before conference call; Patriot Coal around 30
|
| 7/3/2012 | CV | Market Commentary: Convertibles quiet ahead of holiday; Lincare, Theravance extend gains; U.S. Steel better
|
| 7/2/2012 | CV | Market Commentary: Lincare jumps on hedged basis on Linde takeout; Amylin up outright on Bristol-Myers deal
|
| 4/25/2012 | CV | Market Commentary: Iconix falls outright, flat to lower on hedge; Allegheny flat; Amylin up on lawsuit's end
|
| 4/23/2012 | CV | Market Commentary: Central European Distribution jumps on investment; Amylin up; James River Coal plunges
|
| 4/2/2012 | CV | Market Commentary: Convertibles flat to weaker: Gilead weaker, unchanged on hedge; James River down on hedge
|
| 3/30/2012 | CV | Market Commentary: Sino-Forest weaker on bankruptcy filing; United Rentals moves higher; Amylin extends gains
|
| 3/29/2012 | CV | Market Commentary: Omnicare active, holders make 5 points on exchange; Illumina adds on hedge; Amylin gains
|
| 3/28/2012 | CV | Amylin convertibles appear attractive in light of a potential Bristol-Myers takeover: Barclays
|
| 3/28/2012 | CV | Market Commentary: Amylin adds on word of Bristol-Myers offer; Actuant down on hedge on call; Synnex mixed
|
| 1/30/2012 | CV | Market Commentary: Amylin active; Theravance better bid; MF Global 'comes in'; RadioShack warns on earnings
|
| 1/27/2012 | CV | Market Commentary: Amylin shoots up on Bydureon clearance; Ford up ex-dividend; United Continental adds
|
| 11/8/2011 | CV | Market Commentary: Amylin sinks on severed Lilly alliance; Radian, DryShips improve; CEDC steady in trade
|
| 7/8/2011 | CV | Market Commentary: Convertibles quiet; Amylin adds 2 points on positive drug data; Kinetic up by 0.5 point
|
| 4/20/2011 | CV | Market Commentary: EMC gains on earnings; Textron slips on miss; Amgen up ahead of report; Amylin continues rally
|
| 4/18/2011 | BKCV | Amylin posts $475 mln cash at March 31, repays convertible in April
|
| 4/18/2011 | CV | Market Commentary: Convertibles weaken some; Amylin flat; Gilead mostly lower; A123 Systems sheds a point
|
| 4/15/2011 | CV | Market Commentary: New Sunrise Senior Living gains on debut; Amylin higher outright after positive drug news
|
| 3/4/2011 | CV | Market Commentary: NorthStar adds slightly on debut; Central European Distribution drops again; Old Republic lower
|
| 1/27/2011 | CV | Market Commentary: Amylin rises after earnings beat; ProLogis up outright, lower on hedge on merger talk
|
| 1/26/2011 | CV | Market Commentary: Nielsen trades higher on debut; Kodak drops on earnings miss; Hutchinson Technology steady
|
| 10/21/2010 | CV | Market Commentary: Cubist, Amylin in focus, unchanged in trade; Alliance Data, Covanta steady after earnings
|
| 10/20/2010 | CV | Market Commentary: New Cubist trades slightly over par; Amylin gets slammed but pares losses; Gilead quiet
|
| 6/21/2010 | CV | Market Commentary: Biovail gains on merger with Valeant; Amgen up on competitor's drug safety; PPL on tap
|
| 6/18/2010 | CV | Market Commentary: Convertibles muted; Transocean rises; Amylin up on competitor's drug delay; Omnicom active
|
| 4/19/2010 | CV | Market Commentary: AMR, airlines extend losses on volcanic ash problem; Steel Dynamics dips ahead of earnings
|
| 4/16/2010 | CV | Market Commentary: Upsized MGM moves higher on debut; convertibles mostly quiet amid Goldman Sachs lawsuit
|
| 3/15/2010 | CV | Market Commentary: Amylin gains with stock; Knight prices upsized deal at the middle of talk; Group 1 to price
|
| 3/11/2010 | CV | Market Commentary: International Coal trades up on debut; Hologic higher in active trade; Smithfield active
|
| 3/4/2010 | CV | Market Commentary: Priceline issue up in gray market; Take-Two expands; Amylin mostly steady after downgrade
|
| 3/1/2010 | CV | Market Commentary: Millipore a little weaker dollar neutral, but OSI Pharma expands; Amylin, Isis also in trade
|
| 2/26/2010 | CV | Market Commentary: Interpublic rises on earnings; NuVasive up on insurer support; Amylin gains with coverage
|
| 2/11/2010 | CV | Market Commentary: Newmont Mining up in trade; Equinix gains outright; Savvis lower; RadioShack rises to 112
|
| 1/26/2010 | CV | Market Commentary: Convertibles under pressure; EMC recoups; Amylin strengthens; Kinetic Concepts paper in trade
|
| 1/12/2010 | CV | Market Commentary: KKR trades up on debut; Salesforce.com bid fades in the gray; Hutchinson active; Amylin mixed
|
| 12/24/2009 | CV | Market Commentary: Convertibles quiet; Massey lower, but better dollar neutral; Micron, Navistar extend gains
|
| 12/23/2009 | CV | Market Commentary: Convertibles quiet; Micron extends gains; Transocean mixed; Amylin holds up as stock sinks
|
| 7/14/2009 | CV | Market Commentary: Convertibles strong: Kodak up; Amylin gains dollar neutral; miners active; Janus to price
|
| 4/15/2009 | CVSS | Amylin to approve, not recommend, dissident nominees to settle suit
|
| 4/3/2009 | CV | Market Commentary: Convertibles steady; Alcoa quiet but holds gains; Qwest Communications adds, but Amylin eases
|
| 4/2/2009 | CVSS | Amylin director says shareholder group lacks strategy, company moves on convertible, loan provisions
|
| 3/31/2009 | CV | Market Commentary: Teradyne, Ingersoll-Rand trade up in the gray; Alcoa gains in line; Alliant Techsystems weaker
|
| 8/27/2008 | CV | Market Commentary: Amylin, Cell Genesys fall on product bombshells; Bristol-Myers stands pat; Fannie Mae extends gains
|
| 8/25/2008 | CV | Market Commentary: Ford drops to mid 60s amid higher oil; Suntech Power loses 0.5 point; Amylin trades with hopes for Byetta
|
| 8/18/2008 | CV | Market Commentary: Fannie Mae, Huntington edge lower; Amylin expands as shares sink; Cheniere places private deal
|
| 7/31/2008 | CV | Market Commentary: ImClone gains on Bristol-Myers offer; Amylin rises on M&A chatter; Hologic lower after earnings
|
| 6/9/2008 | CV | Market Commentary: Lehman trades mixed; CIT edges higher; Amylin quiet despite Byetta concerns, Bristow deal seen cheap
|
| 5/30/2008 | CV | Market Commentary: AIG gains on Morgan Stanley comments, other financials edge up; Transocean down; Penn Virginia jumps
|
| 8/17/2007 | CV | Market Commentary: Countrywide rebounds; Wild Oats rallies; Rare Hospitality skyrockets on takeover news
|
| 6/5/2007 | CV | Market Commentary: Amylin gains on debut; Integra higher, Ciena, Dendreon quiet in gray; Cogent, Panda launch unusual deals
|
| 6/5/2007 | CV | New Issue: Amylin prices upsized $500 million seven-year convertibles at cheaps to yield 3%, up 40%
|
| 6/4/2007 | CV | Amylin narrows talk on upsized $500 million seven-year convertibles to 2.75%-3%, up 40%
|
| 6/4/2007 | CV | Market Commentary: Solectron surges on buyout; Amylin flat in gray; Dendreon faces borrow problem; Integra, Ciena plan deals
|
| 8/24/2006 | BTCV | Amylin Pharmaceuticals holders convert all 2.25% notes ahead of redemption
|
| 7/25/2006 | CV | Market Commentary: SanDisk jumps with strong earnings; Amylin in line after notes called; UAL prices $726 million deal
|
| 7/24/2006 | BTCV | Amylin Pharmaceuticals to call 2.25% convertibles due 2008
|
| 7/24/2006 | CV | Market Commentary: Amazon.com better ahead of results; ImClone gains on buyout hopes; Amylin drops as call hurdle topples
|
| 7/17/2006 | CV | Market Commentary: Nabors falls with oil prices; Electronics for Imaging brightens with upgrade; Lucent still weak on forecasts
|
| 4/11/2006 | CV | Market Commentary: Bausch and Lomb wider on product scare; Synaptics gains on iPod rumors; Medtronic plans $4 billion deal
|
| 10/28/2005 | CV | Market Commentary: Invitrogen drops, but gains on hedge; Amkor steadies after fall; Nektar weaker
|
| 10/20/2005 | CV | Market Commentary: Convertibles market reverses course after strong start; Cypress pulled down; Amgen, biotechs weaker
|
| 8/29/2005 | CV | Market Commentary: GM trades mixed; Amylin extends gains; but Katrina contributes to quiet market, traders say
|
| 8/25/2005 | CV | Market Commentary: GM, Ford convertibles trade mixed; Amylin rises; new Emdeon issue remains flat
|
| 8/23/2005 | CV | Market Commentary: Brocade convertibles move lower on call; Amylin gains outright but seen lower on a hedged basis
|
| 4/5/2004 | CV | Amylin greenshoe exercised, raising convertibles to $200 million
|
| 3/31/2004 | CV | Market Commentary: Amylin at 102 bid before pricing aggressively; Caesars dips below par; Kerzner bets push past 101
|
| 3/31/2004 | CV | New Issue: Amylin upsized $175 million convertible yields 2.5%, up 45%
|
| 3/30/2004 | CV | Amylin Pharma $150 million convertible talked at 2.5-3.0%, up 40-45%
|
| 3/30/2004 | CV | Market Commentary: Caesars, Kerzner, Impax Labs on tap with FelCor, Regal-Beloit; ON Semicon, Amylin launched
|
| 9/22/2003 | CV | Market Commentary: Motorola gains with stock on CEO departure; BioMarin steady after drug canceled
|
| 7/18/2003 | CV | Amylin greenshoe exercised, raising convertibles to $175 million
|
| 6/18/2003 | CV | Market Commentary: CNet pulled, other new deals sweetened; Reliant upsizes as buyers reach for a fat coupon
|
| 6/18/2003 | CV | New Issue: Amylin Pharmaceuticals $150 million convertibles yield 2.25%, up 33%
|
| 6/17/2003 | CV | Market Commentary: New deal parade marches on; Lattice reoffered at 98, still dives; secondary thin, lower
|
| 6/16/2003 | CV | Amylin Pharmaceuticals $150 million convertibles talked to yield 1.25-1.75%, up 40-45%
|
| 6/16/2003 | CV | Market Commentary: ICOS, Lattice at bat; buzz puts Nextel Partners eyeing another convert after new junk offering
|
